Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 67445-1-Ig - Provider product page
- Provider
- Proteintech Group
- Product name
- HNRNPA2B1 antibody
- Antibody type
- Monoclonal
- Description
- KD/KO validated HNRNPA2B1 antibody (Cat. #67445-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human, mouse, rat and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 3H6F7
- Vial size
- 20ul, 150ul
Submitted references HNRNPA2B1-mediated m(6)A modification of lncRNA MEG3 facilitates tumorigenesis and metastasis of non-small cell lung cancer by regulating miR-21-5p/PTEN axis.
HNRNPA2B1 regulates tamoxifen- and fulvestrant-sensitivity and hallmarks of endocrine resistance in breast cancer cells.
Requirement of splicing factor hnRNP A2B1 for tumorigenesis of melanoma stem cells.
Li K, Gong Q, Xiang XD, Guo G, Liu J, Zhao L, Li J, Chen N, Li H, Zhang LJ, Zhou CY, Wang ZY, Zhuang L
Journal of translational medicine 2023 Jun 12;21(1):382
Journal of translational medicine 2023 Jun 12;21(1):382
HNRNPA2B1 regulates tamoxifen- and fulvestrant-sensitivity and hallmarks of endocrine resistance in breast cancer cells.
Petri BJ, Piell KM, South Whitt GC, Wilt AE, Poulton CC, Lehman NL, Clem BF, Nystoriak MA, Wysoczynski M, Klinge CM
Cancer letters 2021 Oct 10;518:152-168
Cancer letters 2021 Oct 10;518:152-168
Requirement of splicing factor hnRNP A2B1 for tumorigenesis of melanoma stem cells.
Chu M, Wan H, Zhang X
Stem cell research & therapy 2021 Jan 28;12(1):90
Stem cell research & therapy 2021 Jan 28;12(1):90
No comments: Submit comment
No validations: Submit validation data